[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Research Letter
December 2018

National Trends in the Use of Metabolic and Bariatric Surgery Among Pediatric Patients With Severe Obesity

Author Affiliations
  • 1Department of Surgery, Massachusetts General Hospital, Boston
  • 2Harvard Medical School, Boston, Massachusetts
  • 3Department of Surgery, MassGeneral Hospital for Children, Massachusetts General Hospital, Boston
  • 4Codman Center for Clinical Effectiveness in Surgery, Massachusetts General Hospital, Boston
  • 5Massachusetts General Hospital Weight Center, Department of Medicine, Division of Endocrinology-Neuroendocrinology, Harvard Medical School, Boston
  • 6Massachusetts General Hospital Weight Center, Department of Pediatrics, Division of Endocrinology, Harvard Medical School, Boston
  • 7Stanford University School of Medicine, Stanford, California
  • 8Departments of Surgery and Pediatric Surgery, Lucille Packard Children’s Hospital, Palo Alto, California
JAMA Pediatr. 2018;172(12):1191-1192. doi:10.1001/jamapediatrics.2018.3030

Severe pediatric obesity (class II or higher; body mass index [calculated as weight in kilograms divided by height in meters squared] ≥120% above the 95th percentile or ≥35) is a national public health crisis affecting more than 4.5 million children and adolescents in the United States. The prevalence of severe pediatric obesity has increased from 4.0% in 2000 to 6.0% in 2016.1 For children and adolescents with this disease, metabolic and bariatric surgery (MBS) is effective in achieving long-term weight loss and resolution of comorbidities.2,3 We sought to define contemporary trends in the use of MBS among US children, adolescents, and young adults with severe obesity.